91 related articles for article (PubMed ID: 19685150)
1. Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis.
Harfouche R; Basu S; Soni S; Hentschel DM; Mashelkar RA; Sengupta S
Angiogenesis; 2009; 12(4):325-38. PubMed ID: 19685150
[TBL] [Abstract][Full Text] [Related]
2. [High D-glucose alters PI3K and Akt signaling and leads to endothelial cell migration, proliferation and angiogenesis dysfunction].
Yu P; Yu DM; Qi JC; Wang J; Zhang QM; Zhang JY; Tang YZ; Xing QL; Li MZ
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3425-30. PubMed ID: 17313857
[TBL] [Abstract][Full Text] [Related]
3. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
[TBL] [Abstract][Full Text] [Related]
4. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
5. PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation.
Elayappan B; Ravinarayannan H; Pasha SP; Lee KJ; Gurunathan S
Angiogenesis; 2009; 12(4):313-24. PubMed ID: 19657716
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.
Maffucci T; Piccolo E; Cumashi A; Iezzi M; Riley AM; Saiardi A; Godage HY; Rossi C; Broggini M; Iacobelli S; Potter BV; Innocenti P; Falasca M
Cancer Res; 2005 Sep; 65(18):8339-49. PubMed ID: 16166311
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
9. Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas.
Van Meter TE; Broaddus WC; Cash D; Fillmore H
Cancer; 2006 Nov; 107(10):2446-54. PubMed ID: 17041888
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor efficacy by blocking activation of the phosphatidylinositol 3-kinase/Akt pathway during anti-angiogenesis therapy.
Zhao YW; Jin L; Li ZM; Zhao CJ; Wei YQ; Yang HS
Cancer Sci; 2011 Aug; 102(8):1469-75. PubMed ID: 21561530
[TBL] [Abstract][Full Text] [Related]
11. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of PKI-587, a highly potent dual PI3K/mTOR kinase inhibitor.
Mallon R; Feldberg LR; Lucas J; Chaudhary I; Dehnhardt C; Santos ED; Chen Z; dos Santos O; Ayral-Kaloustian S; Venkatesan A; Hollander I
Clin Cancer Res; 2011 May; 17(10):3193-203. PubMed ID: 21325073
[TBL] [Abstract][Full Text] [Related]
13. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway.
Ho FM; Lin WW; Chen BC; Chao CM; Yang CR; Lin LY; Lai CC; Liu SH; Liau CS
Cell Signal; 2006 Mar; 18(3):391-9. PubMed ID: 15970429
[TBL] [Abstract][Full Text] [Related]
14. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation.
Cai WJ; Wang MJ; Moore PK; Jin HM; Yao T; Zhu YC
Cardiovasc Res; 2007 Oct; 76(1):29-40. PubMed ID: 17631873
[TBL] [Abstract][Full Text] [Related]
15. Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells.
Chung BH; Kim JD; Kim CK; Kim JH; Won MH; Lee HS; Dong MS; Ha KS; Kwon YG; Kim YM
Biochem Biophys Res Commun; 2008 Nov; 376(2):404-8. PubMed ID: 18789310
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin stimulates in vitro angiogenesis via a Pyk-2/Src-dependent mechanism.
Cattaneo MG; Lucci G; Vicentini LM
Exp Cell Res; 2009 Nov; 315(18):3210-9. PubMed ID: 19563802
[TBL] [Abstract][Full Text] [Related]
17. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells.
Namkoong S; Lee SJ; Kim CK; Kim YM; Chung HT; Lee H; Han JA; Ha KS; Kwon YG; Kim YM
Exp Mol Med; 2005 Dec; 37(6):588-600. PubMed ID: 16391520
[TBL] [Abstract][Full Text] [Related]
19. Targeting integrins and PI3K/Akt-mediated signal transduction pathways enhances radiation-induced anti-angiogenesis.
Ning S; Chen Z; Dirks A; Husbeck B; Hsu M; Bedogni B; O'Neill M; Powell MB; Knox SJ
Radiat Res; 2007 Jul; 168(1):125-33. PubMed ID: 17722999
[TBL] [Abstract][Full Text] [Related]
20. Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.
Toulany M; Kasten-Pisula U; Brammer I; Wang S; Chen J; Dittmann K; Baumann M; Dikomey E; Rodemann HP
Clin Cancer Res; 2006 Jul; 12(13):4119-26. PubMed ID: 16818713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
